DR. WAN-JEN HONG, M.D,
Osteopathic Medicine at Blake Wilbur Dr, Palo Alto, CA
License number
California A105339
Category
Osteopathic Medicine
Type
Hematology & Oncology
Address
Address
875 Blake Wilbur Dr, Palo Alto, CA 94305
Phone
(650) 498-6000
Organization information
See more information about WAN-JEN HONG at bizstanding.comWan-Jen Hong MD
300 Pasteur Dr, Stanford, CA 94305
Industry:
Internist
Phone:
(650) 814-4230 (Phone)
Wan-Jen Hong
Professional information
Dr. Wan-Jen Hong, Palo Alto CA - MD (Doctor of Medicine)
Specialties:
Internal Medicine
Address:
875 Blake Wilbur Dr, Palo Alto 94304
(650) 498-6000 (Phone)
STANFORD CANCER CENTER
875 Blake Wilbur Dr STE 2327B, Palo Alto 94304
(650) 736-1253 (Phone), (650) 724-5203 (Fax)
(650) 498-6000 (Phone)
STANFORD CANCER CENTER
875 Blake Wilbur Dr STE 2327B, Palo Alto 94304
(650) 736-1253 (Phone), (650) 724-5203 (Fax)
Certifications:
Internal Medicine, 2011
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
Stanford University
Graduated: 2006
Stanford University
Graduated: 2006
Wan-Jen Hong, Palo Alto CA
Specialties:
Internist
Address:
875 Blake Wilbur Dr, Palo Alto, CA 94304
300 Pasteur Dr, Stanford, CA 94305
300 Pasteur Dr, Stanford, CA 94305
Methods And Compositions For Determining Risk Of Treatment Toxicity
US Patent:
2004015, Aug 5, 2004
Filed:
Oct 14, 2003
Appl. No.:
10/686322
Inventors:
Gilbert Chu - Palo Alto CA, US
Virginia Tusher - Belvedere CA, US
Jean Tang - Stanford CA, US
Kerri Rieger - Menlo Park CA, US
Wan-Jen Hong - Palo Alto CA, US
Robert Tibshirani - Stanford CA, US
Virginia Tusher - Belvedere CA, US
Jean Tang - Stanford CA, US
Kerri Rieger - Menlo Park CA, US
Wan-Jen Hong - Palo Alto CA, US
Robert Tibshirani - Stanford CA, US
International Classification:
C12Q001/68
US Classification:
435/006000
Abstract:
Methods are provided for determining whether a patient treated with an anti-proliferative agent is susceptible to toxicity. In practicing the subject methods, an expression profile for the transcriptional response to a therapy is obtained from the patient and compared to a reference profile to determine whether the patient is susceptible to toxicity. In addition, reagents and kits thereof that find use in practicing the subject methods are provided.